From Molecules to Medicine and Beyond NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation).

33 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology

44 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Outsmarting complex diseases with more intelligent medicines Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell …

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes

375 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Syndivia is committed to enhancing treatment options for cancer patients with solid tumors by leveraging the distinctive properties of targeted DAR1 antibody-drug conjugates, which offer improved tumor penetration, stability, and efficacy. Drug development, Biotechnology, Pharmaceuticals, Antibody-drug conjugates, DAR1 ADC, and ADC

173 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Changing the paradigm in Friedreich's ataxia Biointaxis is an academic spin-off focused on the development of gene therapies for neurodegenerative disorders. Biointaxis lead product is a gene therapy product for Friedreich ataxia.

42 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

626 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing

468 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

What You See Is What You Seq - Revolutionary cell analysis solution for fundamental, translational & pharma/biotech R&D Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics.

54 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

153 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology

Focused on generating precision medicines by leveraging the power of single-cell technologies One Biosciences leverages the power of single-cell analysis to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat conditions. One Biosciences is an integrated discovery engine combining a multi-disciplinary team with in-house computational capabilities. One Biosciences is backed by Institut Curie and Home Biosciences.

54 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

630 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Discovering from green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with properties of high added value (of interest to the consumer, farmers and the agri-food industry) and more resistant to stress, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced services in Genomics, Proteomics, Metabolomics, Bioinformatics, Microscopy, Plant Hormone Quantification, DNA Sequencing and Gene Expression Analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomics, Proteomics, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high value enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors.

190 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc...

422 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology

48 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Single-cell sequencing on every benchtop Scipio bioscience had to cease its operations on 18/09/2024. At Scipio bioscience we were passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio wanted to boost the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provided all researchers with empowered autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for …

6 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Member of the Roche Group Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. Genome Engineering, CAR-T cells, Gene Therapy, Gene Editing, Cell Therapy, Adoptive Cell Therapy, Multiple Myeloma, Prostate Cancer, Transposon, Non-viral, Biotechnology, Immunotherapy, Regenerative …

72 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. …

12 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology. We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays. QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations. QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in …

27 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.

164 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology …

64 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible.

297 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Synsight activity is now integrated into @iktos https://iktos.ai/ https://www.linkedin.com/company/iktos/ Synsight was a company created in 2013, by two co-founders PhD Computer aided drug design: Cyril Bauvais (CEO) and Guillaume Bollot (CSO). In july 2024, Synsight was acquired by @iktos, an AI drug discovery company. Its tech is based on AI drug design and cell imaging, including a proprietary cell based assay named MTBench, to profile compounds modulators of protein-protein and protein-RNA interactions, and protein agregation. criblage virtuel, modélisation moléculaire, dynamique moléculaire, QSAR, drug design, chémoinformatique, and drug discovery

54 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. …

45 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics

157 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biocatalysis from Lab to Industrial Scale Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals …

92 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

336 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library

368 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

587 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology

135 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our mission is to focus on the unmet clinical needs of patients suffering from Tenosynovial Giant Cell Tumours (TGCT) SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

46 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transform how you model human biology. Ricoh Biosciences is a global leader in biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human biology and accelerating …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals

49 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents …

10 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the clinically-tested lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit 9dbio.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

46 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

From Sea to Pharmacy ManRos Therapeutics is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors for the treatment of cystic fibrosis. ManRos was founded in 2007 and is led by Dr Laurent MEIJER, Chairman and CSO, former distinguished Director of Research at the CNRS, and Dr Philippe de Lavenne, CEO, former Vice-President at Actelion Pharmaceuticals. For 40 years, Dr Meijer dedicated his research to the study of protein kinases and their inhibitors, mostly at the CNRS. Drug Development, Cystic Fibrosis, and Biotechnology

40 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Built to unlock the power of single-molecule fluorescence spectroscopy Exciting Instruments is revolutionising life science research by making single-molecule detection accessible to every academic and pharma lab worldwide—driving breakthroughs that transform human health. Since its launch in 2022, our cutting-edge platform has empowered researchers to explore single molecules and their interactions like never before. single-molecule fluorescence spectroscopy, smFRET, FCS, drug discovery , protein-protein, protein-DNA, and protein-RNA

57 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering next-generation antibody therapies with AI and computational protein design Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon …

41 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, …

141 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Opening the world of biology to new possibilities Element Biosciences is a life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. Next-Generation Sequencers, DNA, and Biotechnology

56 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute …

39 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

FAST LABORATORY DIAGNOSTICS OaCP, Oncology and Cytogenetic Products, deals with the creation of chemical and biotechnological products for fast diagnostics. We believe that the quality of work in molecular biology and molecular cytogenetics is fundamental, that it can also be economical (Smart-ISH Solve) and - why not - rapid (Rapid-ISH Integra). Thanks to the multi-year research conducted with the University of Bologna, we have developed the DoMo Genetics line of reagents but we don't stop! Our mission is to provide faster, more budget-conscious and easier-to-use tools to the molecular biology laboratory professional, to improve the quality of life of cancer …

Type: Startup Activities: deeptech biotech

Evolving Biology, Advancing Tomorrow Allozymes is a biotechnology company redefining enzyme engineering through its proprietary ultra-high-throughput microfluidic and AI-driven screening platform. By integrating biocatalysis, enzyme discovery, and microfluidic innovation, we accelerate the development of tailored enzymes for biomanufacturing, pharma, and life sciences. With a vision to build the world’s most comprehensive enzyme data library, Allozymes is enabling faster discovery, smarter optimization, and sustainable production across industries. Biocatalysis, Enzyme Engineering, Enzyme Discovery, Microfluidics, AI-Driven Screening, Biomanufacturing, Protein Engineering, Synthetic Biology, Biosolutions, and Data-Driven Enzyme Design

34 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI

284 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology

Nature's pharmacy, re-engineered Biomia is a synthetic biology company developing a pipeline of plant-inspired natural or new-to-nature therapeutic products to address the unmet medical needs in pain, addiction, and mental health conditions.

69 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

212 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Decoding what life wrote Life has been writing for 3 billion years, 97% has never been read. Generare unhearts, decodes, compounds what life wrote. Our platform and team generate high-quality molecular data on unread chemistry, creating the dataset that will define a new paradigm for drug discovery. genomics, synbio, and microbiology

30 similar entities Tags: FrenchTech2030 Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

749 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

DNA Synthesis Uncompromised Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FESTM), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of …

54 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is an end-to-end software solution built to enable biologists run more powerful, high-dimensional experiments and get to biological insight faster. It allows scientists to design, plan, and automate multifactorial experiments in a single place, then automatically gather and structure data and metadata, and analyse multivariate datasets with ease. Life Sciences, Lab Automation, Scientific Consulting, Design of Experiments, Drug Discovery, Assay Development, Software Engineering, and Drug Discovery

53 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Discover your favorite frequencies to boost your drug discovery business CellSine provides devices and software that make advanced electrochemical impedance spectroscopy easily accessible to any microbiological researcher. It delivers a platform tool for a that enables a wide variety of biochemical studies. Biotechnology, Cell culture monitoring, Proteïn - Proteïn interactions, Suspension cultures, Receptor signaling, Biofilm maturation, and T lymphocyte activation

218 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases Now part of Pacira Biosciences. GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene …

47 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

HP Health Solutions Life Sciences, Molecular Assays, Biotechnology, diagnostics, and corporate incubation

276 similar entities Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology

Synthetic Genetic Systems for next generation biomedicines and bioprocesses. SynGenSys creates product-specific libraries of synthetic genetic parts for next-generation biomedicines and biomanufacturing processes. Our philosophy is simple: all products and production processes are unique. Therefore core genetic assemblies used for therapy or biomanufacturing should harbour custom synthetic DNA parts and circuits designed to be fit for a specific purpose. Life Science, Biopharma, Cell Therapy, and Gene Therapy

68 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis

102 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Enabling next generation medicines. A comprehensive platform and product suite for advanced therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics

187 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

322 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Peptide-based therapeutics for treating peripheral pain conditions At Akasi Pharma, we are developing novel peptide-based therapeutics to treat peripheral pain conditions Peptide therapeutics and Peripheral Neuropathic Pain

160 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dedicated to discovering and advancing novel therapeutics that halt or slow the ageing process for healthier lives Genflow Biosciences plc (LON: GENF) (OTCQB: GENFF) is an emerging leader in the field of longevity research with R&D facilities in Belgium and a U.S. office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the aging process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Managed by an experienced team with decades of experience in the pharmaceutical and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Targeting CCN signaling to treat fibrosis Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

186 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics

46 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. A.I. - Machine Learning

Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors.

256 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.

260 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Bringing precision to the power of biologics with pioneering use of synthetic nanoclays for regenerative medicine. Renovos Biologics Ltd. (Renovos) is a biotech/medtech company focussed on the development of its patented synthetic nanoclay, RENOVITE®, as a drug delivery platform for regenerative medicine and beyond. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Orthopaedics, and Biotechnology

116 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines

307 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, …

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology

161 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Producing recombinant proteins with whole fruit flies Future Fields is changing how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use whole fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a Green-certified lab from My Green Lab, a proud business member of 1% for the Planet, and a part of the United Nations Global Compact initiative. Recombinant Proteins, Growth Factors, …

48 similar entities Type: Startup Activities: agritech Technologies: Synthetic Biology

Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics

505 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio

181 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We are a specialist respiratory biotech company focused on severe viral lung infections Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com.

19 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, a wholly owned subsidiary of Evotec SE, is an innovative and trusted CDMO for complex biologics, incl. mAbs, bi/multispecifics, and biosimilars. We provide our partners with highly differentiated services for the development and manufacturing of biologics. Our world-leading AI-driven in silico molecular optimization and continuous bioprocessing platforms combined with our revolutionary J.POD® facilities, which represent a paradigm shift within the industry, are helping to reduce the cost of goods and expand global access to affordable, high-quality biotherapeutics in addition to providing a highly agile …

77 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation

584 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies. Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

98 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, and industrial chemicals, scientists use our synthetic genes, oligo pools, biopharma services, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise …

58 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software.

43 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com) Gene Sinlencing, siRNA RNAi Drugs, Ophtalmology, Biotechnology, RNAi, R&D, Pharmaceuticals, Bioinformatics, Biotecología, Biotech, Experimental drugs, Glaucoma, Dry eye syndrome, Target Therapies, Production, eyes diseases, RNAi Clinical Trials, Ophthalmology, Licensing, Research, Drug Discovey, and Rational Design

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy

38 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

702 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology